Global Hematology Diagnostics Market Size To Exceed USD 8.05 Billion By 2035 | CAGR of 6.52%
Category: HealthcareGlobal Hematology Diagnostics Market Size To Exceed USD 8.05 Billion By 2035
According to a research report published by Spherical Insights & Consulting, the Global Hematology Diagnostics Market Size is Expected to Grow from USD 4.02 Billion in 2024 to USD 8.05 Billion by 2035, at a CAGR of 6.52% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 210 pages with 130 Market data tables and figures & charts from the report on the "Global Hematology Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instrument and Consumables), By Test (Blood Count, Platelet Function, Hemoglobin, and Hematocrit), By End Use (Hospitals, Diagnostic labs, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/hematology-diagnostics-market
The hematology diagnostics market is the industry for tools and services used for the diagnosis and monitoring of blood diseases, encompassing a wide range of tests and instruments. Hematology diagnostics aid in determining the causes of blood disorders, including anemia, bleeding problems, and even certain cancers, like leukemia. The market demand for hematology diagnostics is primarily driven by the increasing number of blood donations, prevalence of blood disorders, and demand for sophisticated diagnostic solutions. The integration of automation technology is creating new growth opportunities in the hematology diagnostics market. An increasing prevalence of blood disorders, like anemia, with a growing public health concern is driving the market demand. Further, the use of advanced technologies, including laser-based flow cytometry, automation, and AI/ML algorithms, is propelling the market growth. On the contrary, an increased cost of advanced diagnostic instruments, regulatory challenges, a lack of skilled workforce, and data security concerns are restraining the market.
The consumables segment dominated the market with a major market share in 2024 and is projected to grow at the fastest CAGR during the forecast period.
Based on the product, the hematology diagnostics market is divided into instrument and consumables. Among these, the consumables segment dominated the market with a major market share in 2024 and is projected to grow at the fastest CAGR during the forecast period. An increasing need for diagnosis of blood disorders & other infections, as well as the development of consumables like reagents for hematology analyzers, are propelling the market.
The blood count segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the test, the hematology diagnostics market is divided into blood count, platelet function, hemoglobin, and hematocrit. Among these, the blood count segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The growing consumer inclination towards having frequent WBC tests owing to the increasing awareness about chronic disease conditions like Neutropenia leads to drives the market demand.
The hospitals segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end use, the hematology diagnostics market is divided into hospitals, diagnostic labs, and others. Among these, the hospitals segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing hematology diagnostics in hospital medical labs for disease diagnosis, detecting illegal drug use, thyroid function assessment, and other purposes is propelling the market demand.
North America is expected to hold the majority share of the global hematology diagnostics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global hematology diagnostics market during the forecast period. As per the report of the Leukemia and Lymphoma Society, 184,720 people are estimated to be diagnosed with leukemia, lymphoma, or myeloma in the US. The rising prevalence of blood-related diseases, including anemia, haemophilia, leukemia, sickle cell anemia, and lymphoma, as well as other infections, is anticipated to drive the market demand.
Asia Pacific is anticipated to grow at the fastest pace in the global hematology diagnostics market during the forecast period. A growing incidence of blood disorders and increasing mortality rates due to hematologic malignancies, along with the growing investments and government support, are propelling the hematology diagnostics market.
Europe is anticipated to hold a significant share of the hematology diagnostics market during the projected timeframe. Advancements in diagnostic technologies, along with increasing healthcare spending, are driving the market growth. Further, the introduction of innovative technologies, such as in vitro diagnostic devices also propelling the market.
Major vendors in the global hematology diagnostics market are Abbott, Beckman Coulter, Inc., Sysmex Corporation, Horiba, Bio-Rad Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., NIHON KOHDEN CORPORATION., EKF Diagnostics, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2024, Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of their long-term partnership to include a global distribution agreement of Scopio’s full-field bone marrow Aspirate application. Scopio’s X100 / X100HT with FF-BMA Application is CE-Marked.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the hematology diagnostics market based on the below-mentioned segments:
Global Hematology Diagnostics Market, By Product
- Instrument
- Consumables
Global Hematology Diagnostics Market, By Test
- Blood Count
- Platelet Function
- Hemoglobin
- Hematocrit
Global Hematology Diagnostics Market, By End Use
- Hospitals
- Diagnostic labs
- Others
Global Hematology Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?